NasdaqGS:AMRXPharmaceuticals
Amneal Pharmaceuticals (AMRX) Valuation After Opioid Settlement Finalization And S&P Index Additions
Amneal Pharmaceuticals (AMRX) just stepped into the spotlight as its stock reacts to two big developments: the nationwide opioids settlement becoming effective and the company’s fresh inclusion in several S&P indices.
See our latest analysis for Amneal Pharmaceuticals.
The latest developments sit on top of a clear upswing in the stock, with a 30 day share price return of 13.53% and a 90 day share price return of 23.76%. The 1 year total shareholder return of 80.83% and the very large 3 year...